tiprankstipranks
Advertisement
Advertisement
Biogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
PremiumThe FlyBiogen CELIA topline readout in Alzheimer’s ‘historic,’ says H.C. Wainwright
16d ago
Dyne Therapeutics price target raised to $24 from $23 at Bernstein
Premium
The Fly
Dyne Therapeutics price target raised to $24 from $23 at Bernstein
18d ago
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
Premium
The Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
18d ago
Dyne Therapeutics Advances Pivotal DYNE-101 Trial in Myotonic Dystrophy Type 1
PremiumCompany AnnouncementsDyne Therapeutics Advances Pivotal DYNE-101 Trial in Myotonic Dystrophy Type 1
1M ago
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
2M ago
Buy Rating on Dyne Therapeutics Driven by Robust Phase 3 DM1 Endpoint Strategy and Emerging Disease‑Modification Data
Premium
Ratings
Buy Rating on Dyne Therapeutics Driven by Robust Phase 3 DM1 Endpoint Strategy and Emerging Disease‑Modification Data
3M ago
Dyne Therapeutics price target lowered to $50 from $60 at H.C. Wainwright
PremiumThe FlyDyne Therapeutics price target lowered to $50 from $60 at H.C. Wainwright
3M ago
Dyne Therapeutics reports Q4 EPS (76c), consensus (76c)
Premium
The Fly
Dyne Therapeutics reports Q4 EPS (76c), consensus (76c)
3M ago
Dyne Therapeutics announces upcoming presentations at MDA Conference
Premium
The Fly
Dyne Therapeutics announces upcoming presentations at MDA Conference
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100